Sciences Ltd. Roivant serves as Executive at Axovant Sciences Ltd., where they oversee executive responsibilities. Since joining the company, Sciences Ltd. Roivant has executed 57 insider transactions totaling $648.2M, demonstrating a bullish approach to their equity position. Their most recent transaction on May 17, 2019 involved purchasing 6,200 shares valued at $45.6K.
Sciences Ltd. Roivant currently holds 113,317,007 shares of Axovant Sciences Ltd. (AXON), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Sciences Ltd. Roivant has been a net buyer of AXON stock. They have purchased $648.2M and sold $0 worth of shares.
Sciences Ltd. Roivant's most recent insider trade was on May 17, 2019, when they purchased 6,200 shares at $7.36 per share.
Get notified when new Form 4 filings are submitted
| $6.79 |
| Discretionary |
| Mar 18, 2019 | AXON | $10.0M | Purchase | 6,666,667 | $1.50 | Discretionary |
| Dec 18, 2018 | AXON | $10.0M | Purchase | 10,000,000 | $1.00 | Discretionary |
| Oct 1, 2018 | UROV | $37.5M | Purchase | 2,678,571 | $14.00 | Discretionary |
| Jun 5, 2018 | AXON | $25.0M | Purchase | 14,285,714 | $1.75 | Discretionary |
| Apr 2, 2018 | MYOV | $22.5M | Purchase | 1,110,015 | $20.27 | Discretionary |